Trials / Completed
CompletedNCT01783262
The Role of Extracorporeal Shock Wave Therapy in the Treatment of Trapezial-Metacarpal Osteoarthritis. A Double Blind Randomized Controlled Study.
The Role of Extracorporeal Shock Wave Therapy in the Treatment of Trapezial-Metacarpal Osteoarthritis.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- University of Roma La Sapienza · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Evaluate if extracorporeal shock wave therapy is more effective than sham treatment in patients with trapezial-metacarpal osteoarthritis in pain relief and functional improvement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Extracorporeal shock wave therapy STORZ MEDICAL Modulith SLK | an energy level of 0.09 mJ/mm2, 2400 pulses once a week for 4 weeks. |
| DEVICE | Device: Sham extracorporeal shock wave therapy STORZ MEDICAL Modulith SLK |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2011-06-01
- First posted
- 2013-02-04
- Last updated
- 2013-02-04
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01783262. Inclusion in this directory is not an endorsement.